Source link : https://newshealth.biz/health-news/significant-weight-loss-with-cagrisema-but-less-than-hoped/
CHICAGO — CagriSema, a new weekly injection from Novo Nordisk combining the amylin analogue cagrilintide with the GLP-1 receptor agonist semaglutide, significantly reduced weight and improved glycemic control and cardiometabolic measures in individuals with overweight/obesity and both overweight/obesity and type 2 diabetes, new research showed. In REDEFINE 1, patients with overweight/obesity without diabetes who were […]
The post Significant Weight Loss With CagriSema, But Less Than Hoped first appeared on News Health.
—-
Author : News Health
Publish date : 2025-06-23 19:55:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8